Similar articles

• Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.

  Pace D. Pace D. Expert Rev Vaccines. 2009 May;8(5):529-42. doi: 10.1586/erv.09.18. Expert Rev Vaccines. 2009. PMID: 19397410 Review.
• Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.

  Kafetzis DA, Stamboulidis KN, Tzanakaki G, Kourea Kremastinou J, Skevaki CL, Konstantopoulos A, Tsolia M. Kafetzis DA, et al. Clin Microbiol Infect. 2007 May;13(5):550-2. doi: 10.1111/j.1469-0691.2007.01704.x. Epub 2007 Mar 22. Clin Microbiol Infect. 2007. PMID: 17378929
• Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier.

  Pérez AE, Dickinson FO, Banderas F, Serrano T, Llanes R, Guzmán D, Díaz P, Alvarez A, Guirola M, Caballero E, Canaan-Haden L, Guillén G. Pérez AE, et al. FEMS Immunol Med Microbiol. 2006 Apr;46(3):386-92. doi: 10.1111/j.1574-695X.2006.00047.x. FEMS Immunol Med Microbiol. 2006. PMID: 16553812 Clinical Trial.
• Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.

  Joseph H, Ryall R, Bybel M, Papa T, MacLennan J, Buttery J, Borrow R. Joseph H, et al. J Infect Dis. 2003 Apr 1;187(7):1142-6. doi: 10.1086/368358. Epub 2003 Mar 13. J Infect Dis. 2003. PMID: 12660929
• New frontiers in meningococcal vaccines.

  Anderson AS, Jansen KU, Eiden J. Anderson AS, et al. Expert Rev Vaccines. 2011 May;10(5):617-34. doi: 10.1586/erv.11.50. Expert Rev Vaccines. 2011. PMID: 21604983 Review.